Clinical Management of Hypertrophic Cardiomyopathy: Pharmacological Treatment and Surgical Interventions
Autor(a) principal: | |
---|---|
Data de Publicação: | 2024 |
Outros Autores: | , , , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Brazilian Journal of Implantology and Health Sciences |
Texto Completo: | https://bjihs.emnuvens.com.br/bjihs/article/view/1448 |
Resumo: | This study investigates emerging strategies in the clinical management of Hypertrophic Cardiomyopathy (HCM), adopting an integrative and innovative approach. Initially, advancements in pharmacological therapies are highlighted, focusing on promising agents for treatment and specific modulation that have demonstrated efficacy in preserving cardiac function and reducing disease progression. Beyond pharmacological approaches, the analysis extends to consider interventions exploring the underlying mechanisms of HCM. The identification of molecular targets and emerging biological pathways emphasizes the importance of understanding the disease's pathophysiology for the development of more targeted therapies. Another focal point addresses complementary therapies, such as optimizing surgical strategies and innovative drug delivery methods to enhance efficacy and minimize adverse effects. The analysis includes discussions on advanced surgical techniques and minimally invasive therapeutic approaches, representing significant advances in the pursuit of more effective and well-tolerated treatments. Simultaneously, therapies aiming not only at symptom relief but also at the preservation and improvement of compromised cardiac function are considered. This involves exploring regenerative approaches, such as cellular therapies and growth factors, highlighting their promising contribution to restoring cardiac health. In addition to therapeutic innovations, this work underscores the need for a comprehensive understanding of HCM, including genetic, metabolic, and environmental factors influencing individual responses to proposed therapies. The emphasis on personalized interventions underscores the complexity of the disease and the importance of considering individual patient characteristics. In conclusion, the study emphasizes the importance of a multidisciplinary approach, integrating different therapeutic modalities to optimize outcomes in HCM treatment. The combination of innovative pharmacological approaches, advanced surgical strategies, and regenerative therapies emerges as a promising perspective to comprehensively and effectively address this cardiac challenge. |
id |
GOE-1_f32455e548f7e712e55640afd86f9bf8 |
---|---|
oai_identifier_str |
oai:ojs.bjihs.emnuvens.com.br:article/1448 |
network_acronym_str |
GOE-1 |
network_name_str |
Brazilian Journal of Implantology and Health Sciences |
repository_id_str |
|
spelling |
Clinical Management of Hypertrophic Cardiomyopathy: Pharmacological Treatment and Surgical Interventions Manejo Clínico da Cardiomiopatia Hipertrófica: Tratamento Farmacológico e Intervenções Cirúrgica Cardiomiopatia Hipertrófica; Tratamento Farmacológico; Intervenções Cirúrgicas.Hypertrophic Cardiomyopathy; Pharmacological Treatment; Surgical Interventions.This study investigates emerging strategies in the clinical management of Hypertrophic Cardiomyopathy (HCM), adopting an integrative and innovative approach. Initially, advancements in pharmacological therapies are highlighted, focusing on promising agents for treatment and specific modulation that have demonstrated efficacy in preserving cardiac function and reducing disease progression. Beyond pharmacological approaches, the analysis extends to consider interventions exploring the underlying mechanisms of HCM. The identification of molecular targets and emerging biological pathways emphasizes the importance of understanding the disease's pathophysiology for the development of more targeted therapies. Another focal point addresses complementary therapies, such as optimizing surgical strategies and innovative drug delivery methods to enhance efficacy and minimize adverse effects. The analysis includes discussions on advanced surgical techniques and minimally invasive therapeutic approaches, representing significant advances in the pursuit of more effective and well-tolerated treatments. Simultaneously, therapies aiming not only at symptom relief but also at the preservation and improvement of compromised cardiac function are considered. This involves exploring regenerative approaches, such as cellular therapies and growth factors, highlighting their promising contribution to restoring cardiac health. In addition to therapeutic innovations, this work underscores the need for a comprehensive understanding of HCM, including genetic, metabolic, and environmental factors influencing individual responses to proposed therapies. The emphasis on personalized interventions underscores the complexity of the disease and the importance of considering individual patient characteristics. In conclusion, the study emphasizes the importance of a multidisciplinary approach, integrating different therapeutic modalities to optimize outcomes in HCM treatment. The combination of innovative pharmacological approaches, advanced surgical strategies, and regenerative therapies emerges as a promising perspective to comprehensively and effectively address this cardiac challenge. Este estudo investiga estratégias emergentes no manejo clínico da Cardiomiopatia Hipertrófica (CMH), adotando uma abordagem integrativa e inovadora. Inicialmente, destacam-se avanços nas terapias farmacológicas, com foco em agentes promissores para o tratamento e modulação específica que demonstraram eficácia na preservação da função cardíaca e na redução da progressão da doença. Além das abordagens farmacológicas, a análise se estende para considerar intervenções que exploram os mecanismos subjacentes à CMH. A identificação de alvos moleculares e vias biológicas emergentes destaca a importância de compreender a fisiopatologia da doença para o desenvolvimento de terapias mais direcionadas. Outro ponto de destaque aborda terapias complementares, como otimização de estratégias cirúrgicas e métodos inovadores de entrega de medicamentos para aprimorar a eficácia e minimizar efeitos adversos. A análise inclui discussões sobre técnicas cirúrgicas avançadas e abordagens terapêuticas minimamente invasivas, representando avanços significativos na busca por tratamentos mais eficazes e bem tolerados. Paralelamente, são consideradas terapias que visam não apenas o alívio dos sintomas, mas também a preservação e melhoria da função cardíaca comprometida. Isso envolve a exploração de abordagens regenerativas, como terapias celulares e fatores de crescimento, destacando sua promissora contribuição para a restauração da saúde cardíaca. Além das inovações terapêuticas, este trabalho sublinha a necessidade de uma compreensão abrangente da CMH, incluindo fatores genéticos, metabólicos e ambientais que influenciam a resposta individual às terapias propostas. A ênfase na personalização das intervenções destaca a complexidade da doença e a importância de considerar as características individuais dos pacientes. Ao final, destaca-se a importância de uma abordagem multidisciplinar, integrando diferentes modalidades terapêuticas para otimizar os resultados no tratamento da CMH. A combinação de abordagens farmacológicas inovadoras, estratégias cirúrgicas avançadas e terapias regenerativas emerge como uma perspectiva promissora para enfrentar esse desafio cardíaco de forma abrangente e eficaz.Specialized Dentistry Group2024-02-14info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://bjihs.emnuvens.com.br/bjihs/article/view/144810.36557/2674-8169.2024v6n2p1311-1325Brazilian Journal of Implantology and Health Sciences ; Vol. 6 No. 2 (2024): BJIHS QUALIS B3; 1311-1325Brazilian Journal of Implantology and Health Sciences ; Vol. 6 Núm. 2 (2024): BJIHS QUALIS B3; 1311-1325Brazilian Journal of Implantology and Health Sciences ; v. 6 n. 2 (2024): BJIHS QUALIS B3; 1311-13252674-8169reponame:Brazilian Journal of Implantology and Health Sciencesinstname:Grupo de Odontologia Especializada (GOE)instacron:GOEporhttps://bjihs.emnuvens.com.br/bjihs/article/view/1448/1657Copyright (c) 2024 Eloísa Leal Silva Marim , Amanda de Andrade Gomes, Luana Laurito Batista, Andressa Fonseca Sampaio, Gabriel de Assis Carnelós, André Gontijo Perez de Queiroz, Luiz Felipe Ayres Furtado, Izaias Longhitano Neto, Lethycia Milhomem Martins , Allexia Zopé Sartório Brum , Leticia Januzzi Resendehttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessLeal Silva Marim , Eloísade Andrade Gomes, Amanda Laurito Batista, LuanaFonseca Sampaio, Andressade Assis Carnelós, GabrielGontijo Perez de Queiroz, AndréFelipe Ayres Furtado, Luiz Longhitano Neto, IzaiasMilhomem Martins , Lethycia Zopé Sartório Brum , AllexiaJanuzzi Resende, Leticia2024-02-14T21:48:54Zoai:ojs.bjihs.emnuvens.com.br:article/1448Revistahttps://bjihs.emnuvens.com.br/bjihsONGhttps://bjihs.emnuvens.com.br/bjihs/oaijournal.bjihs@periodicosbrasil.com.br2674-81692674-8169opendoar:2024-02-14T21:48:54Brazilian Journal of Implantology and Health Sciences - Grupo de Odontologia Especializada (GOE)false |
dc.title.none.fl_str_mv |
Clinical Management of Hypertrophic Cardiomyopathy: Pharmacological Treatment and Surgical Interventions Manejo Clínico da Cardiomiopatia Hipertrófica: Tratamento Farmacológico e Intervenções Cirúrgica |
title |
Clinical Management of Hypertrophic Cardiomyopathy: Pharmacological Treatment and Surgical Interventions |
spellingShingle |
Clinical Management of Hypertrophic Cardiomyopathy: Pharmacological Treatment and Surgical Interventions Leal Silva Marim , Eloísa Cardiomiopatia Hipertrófica; Tratamento Farmacológico; Intervenções Cirúrgicas. Hypertrophic Cardiomyopathy; Pharmacological Treatment; Surgical Interventions. |
title_short |
Clinical Management of Hypertrophic Cardiomyopathy: Pharmacological Treatment and Surgical Interventions |
title_full |
Clinical Management of Hypertrophic Cardiomyopathy: Pharmacological Treatment and Surgical Interventions |
title_fullStr |
Clinical Management of Hypertrophic Cardiomyopathy: Pharmacological Treatment and Surgical Interventions |
title_full_unstemmed |
Clinical Management of Hypertrophic Cardiomyopathy: Pharmacological Treatment and Surgical Interventions |
title_sort |
Clinical Management of Hypertrophic Cardiomyopathy: Pharmacological Treatment and Surgical Interventions |
author |
Leal Silva Marim , Eloísa |
author_facet |
Leal Silva Marim , Eloísa de Andrade Gomes, Amanda Laurito Batista, Luana Fonseca Sampaio, Andressa de Assis Carnelós, Gabriel Gontijo Perez de Queiroz, André Felipe Ayres Furtado, Luiz Longhitano Neto, Izaias Milhomem Martins , Lethycia Zopé Sartório Brum , Allexia Januzzi Resende, Leticia |
author_role |
author |
author2 |
de Andrade Gomes, Amanda Laurito Batista, Luana Fonseca Sampaio, Andressa de Assis Carnelós, Gabriel Gontijo Perez de Queiroz, André Felipe Ayres Furtado, Luiz Longhitano Neto, Izaias Milhomem Martins , Lethycia Zopé Sartório Brum , Allexia Januzzi Resende, Leticia |
author2_role |
author author author author author author author author author author |
dc.contributor.author.fl_str_mv |
Leal Silva Marim , Eloísa de Andrade Gomes, Amanda Laurito Batista, Luana Fonseca Sampaio, Andressa de Assis Carnelós, Gabriel Gontijo Perez de Queiroz, André Felipe Ayres Furtado, Luiz Longhitano Neto, Izaias Milhomem Martins , Lethycia Zopé Sartório Brum , Allexia Januzzi Resende, Leticia |
dc.subject.por.fl_str_mv |
Cardiomiopatia Hipertrófica; Tratamento Farmacológico; Intervenções Cirúrgicas. Hypertrophic Cardiomyopathy; Pharmacological Treatment; Surgical Interventions. |
topic |
Cardiomiopatia Hipertrófica; Tratamento Farmacológico; Intervenções Cirúrgicas. Hypertrophic Cardiomyopathy; Pharmacological Treatment; Surgical Interventions. |
description |
This study investigates emerging strategies in the clinical management of Hypertrophic Cardiomyopathy (HCM), adopting an integrative and innovative approach. Initially, advancements in pharmacological therapies are highlighted, focusing on promising agents for treatment and specific modulation that have demonstrated efficacy in preserving cardiac function and reducing disease progression. Beyond pharmacological approaches, the analysis extends to consider interventions exploring the underlying mechanisms of HCM. The identification of molecular targets and emerging biological pathways emphasizes the importance of understanding the disease's pathophysiology for the development of more targeted therapies. Another focal point addresses complementary therapies, such as optimizing surgical strategies and innovative drug delivery methods to enhance efficacy and minimize adverse effects. The analysis includes discussions on advanced surgical techniques and minimally invasive therapeutic approaches, representing significant advances in the pursuit of more effective and well-tolerated treatments. Simultaneously, therapies aiming not only at symptom relief but also at the preservation and improvement of compromised cardiac function are considered. This involves exploring regenerative approaches, such as cellular therapies and growth factors, highlighting their promising contribution to restoring cardiac health. In addition to therapeutic innovations, this work underscores the need for a comprehensive understanding of HCM, including genetic, metabolic, and environmental factors influencing individual responses to proposed therapies. The emphasis on personalized interventions underscores the complexity of the disease and the importance of considering individual patient characteristics. In conclusion, the study emphasizes the importance of a multidisciplinary approach, integrating different therapeutic modalities to optimize outcomes in HCM treatment. The combination of innovative pharmacological approaches, advanced surgical strategies, and regenerative therapies emerges as a promising perspective to comprehensively and effectively address this cardiac challenge. |
publishDate |
2024 |
dc.date.none.fl_str_mv |
2024-02-14 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://bjihs.emnuvens.com.br/bjihs/article/view/1448 10.36557/2674-8169.2024v6n2p1311-1325 |
url |
https://bjihs.emnuvens.com.br/bjihs/article/view/1448 |
identifier_str_mv |
10.36557/2674-8169.2024v6n2p1311-1325 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
https://bjihs.emnuvens.com.br/bjihs/article/view/1448/1657 |
dc.rights.driver.fl_str_mv |
https://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Specialized Dentistry Group |
publisher.none.fl_str_mv |
Specialized Dentistry Group |
dc.source.none.fl_str_mv |
Brazilian Journal of Implantology and Health Sciences ; Vol. 6 No. 2 (2024): BJIHS QUALIS B3; 1311-1325 Brazilian Journal of Implantology and Health Sciences ; Vol. 6 Núm. 2 (2024): BJIHS QUALIS B3; 1311-1325 Brazilian Journal of Implantology and Health Sciences ; v. 6 n. 2 (2024): BJIHS QUALIS B3; 1311-1325 2674-8169 reponame:Brazilian Journal of Implantology and Health Sciences instname:Grupo de Odontologia Especializada (GOE) instacron:GOE |
instname_str |
Grupo de Odontologia Especializada (GOE) |
instacron_str |
GOE |
institution |
GOE |
reponame_str |
Brazilian Journal of Implantology and Health Sciences |
collection |
Brazilian Journal of Implantology and Health Sciences |
repository.name.fl_str_mv |
Brazilian Journal of Implantology and Health Sciences - Grupo de Odontologia Especializada (GOE) |
repository.mail.fl_str_mv |
journal.bjihs@periodicosbrasil.com.br |
_version_ |
1796798444475514880 |